AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

As of July 30, 2026, AKTX stock price declined to $8.00 with 69,066 million shares trading.

AKTX has a beta of 3.31, meaning it tends to be more sensitive to market movements. AKTX has a correlation of 0.04 to the broad based SPY ETF.

AKTX has a market cap of $14.00 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AKTX traded as high as $220.00 and as low as $3.02.

AKTX has underperformed the market in the last year with a price return of -81.5% while the SPY ETF gained +17.9%. However, in the short term, AKTX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +52.7% vs +4.5% return in SPY. But in the last 2 weeks, AKTX shares have been beat by the market, returning -33.7% compared to an SPY return of -1.7%.

AKTX support price is $7.24 and resistance is $9.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX shares will trade within this expected range on the day.